Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

NCT02279966 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Vortioxetine 10 mg
DRUG: Paroxetine 20 mg
DRUG: Placebo

Sponsor

H. Lundbeck A/S